Nobel Prize in Medicine 2025: Discoveries in Autoimmune Regulation and Regulatory T-cells
The 2025 Nobel Prize in Physiology or Medicine was awarded to Mary Brunkow, Fred Ramsdell, and Shimon Sakaguchi for their groundbreaking work on autoimmune regulation. They identified the role of regulatory T-cells (Tregs) and the transcription factor FOXP3. Sakaguchi discovered Tregs in 1995, while Brunkow and Ramsdell identified the FOXP3 gene. Mutations in FOXP3 lead to IPEX, a lethal autoimmune disorder. Their research transformed the understanding of the immune system from a simple on/off switch to a dynamic ecosystem of activation and restraint, opening doors for new treatments for cancer and autoimmune diseases.
Key Points
- The laureates identified regulatory T-cells (Tregs) which prevent the immune system from attacking the body's own cells.
- The FOXP3 gene was identified as the master regulator for the development and function of Tregs.
- This discovery has significant implications for treating autoimmune diseases, cancer, and improving organ transplant success.
- The work shifted the conceptual understanding of the immune system to a dynamic ecosystem of activation and restraint.
Exam Facts
- Laureates: Mary E. Brunkow, Fred Ramsdell, and Shimon Sakaguchi.
- Key Gene: FOXP3 (Forkhead box P3).
- Condition: IPEX (Immune dysregulation, polyendocrinopathy, enteropathy, X-linked) syndrome.
Read it. Retain it. Recall it.
Get spaced-repetition flashcards, daily quizzes and offline access — free on Android.